Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-Early Clinical Studies Group (ECSG)
Open Access
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier
- Vol. 12 (9) , 1289-1293
- https://doi.org/10.1023/a:1012287111922
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit:
- Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell CycleJournal of Medicinal Chemistry, 1999